Prof Stephen Kent
Professorial Fellow
Department of Microbiology and Immunology
521 Scholarly works
100 Projects
HIGHLIGHTS
2026
Journal article
Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidity
DOI: 10.1038/s41467-026-73988-z2026
Journal article
Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities
DOI: 10.1016/j.addr.2026.1159252026
Journal article
Neutralising antibodies and protection from progression to severe COVID-19: A meta-analysis.
DOI: 10.1371/journal.pmed.10052302023
Research Grant
Biologics for the Prophylaxis and Treatment of COVID19
2022
Research grants (ARC, NHMRC, MRFF)
Immune Responses to SARS-CoV-2 Variants Across Age Groups and Vulnerable Populations
2021
Journal article
Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: Implications for COVID-19 pathogenesis and consequences
DOI: 10.1183/13993003.03730-20202019
Research Grant
Addressing the Major Challenges in Hiv Vaccine and Cure Research
RECENT SCHOLARLY WORKS
2026
Journal article
Pre-existing systemic and nasal antibodies against avian H5 influenza A viruses vary according to childhood imprinting.
DOI: 10.1128/mbio.01892-262026
Journal article
Epistasis facilitates the long-term antigenic evolution of the influenza B virus hemagglutinin.
DOI: 10.64898/2026.07.22.7399942026
Journal article
Systems serology identifies FcR-related autoantibody signatures and functions for Sjögren’s syndrome
DOI: 10.1038/s44321-026-00458-w2026
Journal article
Immune responses associated with protection from SARS-CoV-2 infection
DOI: 10.1016/j.vaccine.2026.1285792026
Journal article
High-dimensional multiomics reveals perturbations to IL-6/IL-6R axis and RUNX3 in CD4 T cells during third-trimester pregnancy
DOI: 10.1002/cti2.700962026
Journal article
IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccination
DOI: 10.1038/s44321-026-00395-82026
Journal article
Age-related differences in mRNA vaccine immunogenicity and adjuvancy
DOI: 10.1111/imcb.70102
RECENT PROJECTS
2025
Research grants (ARC, NHMRC, MRFF)
Antibody Cocktails Against COVID-19 - WHODrug Global License Agreement